BRIAN DIAZ, RPH, PHARMD, MS
Pharmacy at 15 Ave, Seattle, WA
License number
Washington PH60267031
Category
Pharmacy
Type
Pharmacist
Address
Address
109 15Th Ave, Seattle, WA 98122
Phone
(206) 890-0150
Professional information
Brian Diaz
Work:
Innovative Men's Clinic - Bellevue, WA
Medical Assistant Extern Bio-Therapeutic - Seattle, WA Genie, Construction Equipment - Redmond, WA
Painter Safeway Madison Street Location - Seattle, WA
Night Stocker Mount Si Rehabilitation Center - North Bend, WA
Medical Assistant Extern Bio-Therapeutic - Seattle, WA Genie, Construction Equipment - Redmond, WA
Painter Safeway Madison Street Location - Seattle, WA
Night Stocker Mount Si Rehabilitation Center - North Bend, WA
Education:
Pima Medical Institute - Seattle, WA
Certificate in Medical
Certificate in Medical
Substituted Benzimidazoles And Methods Of Preparation
US Patent:
7767820, Aug 3, 2010
Filed:
May 5, 2008
Appl. No.:
12/151995
Inventors:
Martin Dimitroff - Seattle WA, US
Bridget R. Miller - Lynnwood WA, US
Brady S. Stillwell - Gregory MI, US
David A. Siesel - San Diego CA, US
Tyson Swiftney - Bellevue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan P. Van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel J. Poon - Oakland CA, US
Teresa E. Pick - Danville CA, US
Bridget R. Miller - Lynnwood WA, US
Brady S. Stillwell - Gregory MI, US
David A. Siesel - San Diego CA, US
Tyson Swiftney - Bellevue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan P. Van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel J. Poon - Oakland CA, US
Teresa E. Pick - Danville CA, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
C07D 401/14
US Classification:
5462734
Abstract:
Methods for preparing new substituted benzimidazole compounds having formula (I) useful for treating kinase mediated disorders are provided wherein R, R, R, R, a, b, and c are defined herein.
Substituted Benzimidazoles And Methods Of Preparation
US Patent:
2010025, Oct 7, 2010
Filed:
Jun 18, 2010
Appl. No.:
12/818971
Inventors:
Martin Dimitroff - Seattle WA, US
Bridget R. Miller - Mynnwood WA, US
Brady S. Stillwell - Gregory MI, US
David A. Siesel - San Diego CA, US
Tyson Swiftney - Bellenue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan P. van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel J. Poon - Oakland CA, US
Teresa E. Pick - Danville CA, US
Bridget R. Miller - Mynnwood WA, US
Brady S. Stillwell - Gregory MI, US
David A. Siesel - San Diego CA, US
Tyson Swiftney - Bellenue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan P. van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel J. Poon - Oakland CA, US
Teresa E. Pick - Danville CA, US
International Classification:
C07D 403/14, C07D 401/14
US Classification:
544364, 5462734, 546256
Abstract:
Methods for preparing new substituted benzimidazole compounds having formula (I) useful for treating kinase mediated disorders are provided wherein R, R, R, R, a, b, and c are defined herein
Substituted Benzimidazoles And Methods Of Preparation
US Patent:
2007004, Mar 1, 2007
Filed:
Aug 30, 2006
Appl. No.:
11/513745
Inventors:
Martin Dimitroff - Seattle WA, US
Bridget Miller - Lynnwood WA, US
Brady Stillwell - Gregory MI, US
David Siesel - San Diego CA, US
Tyson Swiftney - Bellevue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel Poon - Oakland CA, US
Teresa Pick - Danville CA, US
Bridget Miller - Lynnwood WA, US
Brady Stillwell - Gregory MI, US
David Siesel - San Diego CA, US
Tyson Swiftney - Bellevue WA, US
Brian Diaz - Seattle WA, US
Danlin Gu - Kirkland WA, US
Jonathan van Dyck - Seattle WA, US
David Ryckman - Bellevue WA, US
Daniel Poon - Oakland CA, US
Teresa Pick - Danville CA, US
International Classification:
A61K 31/4439, C07D 403/14
US Classification:
514338000, 546272400
Abstract:
Methods for preparing new substituted benzimidazole compounds having formula (I) useful for treating kinase mediated disorders are provided wherein R, R, R, R, a, b, and c are defined herein